Anzeige
Mehr »
Samstag, 07.02.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
19 Leser
Artikel bewerten:
(0)

AMICAS Announces Integrations at More Than 100 MEDITECH Facilities

BOSTON, May 27 /PRNewswire-FirstCall/ -- AMICAS, Inc. , a leader in radiology and medical image and information management solutions, today announced that it has successfully integrated its Vision Series(TM) PACS at more than 100 facilities that use MEDITECH(TM) as their health information system. AMICAS will be showcasing Vision Series PACS at the 2008 International Medical Users Software Exchange (MUSE) Conference in Dallas, TX, from May 27 to 30. AMICAS will be in booth #530.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO )

"AMICAS has a proven track record of successfully implementing our PACS at more than 100 MEDITECH facilities across the country," said Paul Merrild, vice president of marketing at AMICAS. "Many facilities throughout the country have made an investment in MEDITECH -- and AMICAS allows them to fully leverage their investment when they choose our Vision Series PACS."

AMICAS is focused on developing solutions that allow facilities running a MEDITECH health information system to realize superior integration and value from their investment with MEDITECH. Complementing MEDITECH's core applications, the AMICAS product suite includes the following functionality:

-- Vision Series PACS offers the capability to securely launch an encrypted image viewer that is embedded within numerous MEDITECH products, including PCI and EMR. This allows users in other MEDITECH applications to be "image-aware" without disrupting their daily workflow, seamlessly launching the AMICAS products on an as-needed basis. -- Vision Watch(TM) offers reporting functionality that complements the tools found in the MEDITECH RIS. These capabilities empower radiology administrators with easily accessible information required to run their departments and facilities effectively, such as data on referring physician volume reports, imaging equipment utilization, and HIPAA reporting needs -- all in a Web-based, drill-down, "point and click" user interface. -- Vision Series PACS includes a bi-directional interface with all MEDITECH platforms. This interface returns relevant clinical data to radiologists at their PACS workstations in order to enhance their ability to diagnose their patients, thus increasing their efficiency and that of the entire radiology department or facility.

"AMICAS' dedication to making MEDITECH customers successful extends beyond technical capabilities. We have invested, and will continue to invest, in products and services that complement those provided by MEDITECH. We focus on being collaborative and cooperative with MEDITECH for the benefit of our mutual customers. We believe this focus differentiates us from other PACS companies in the market," said Mr. Merrild.

AMICAS, Vision Series, and Vision Watch are trademarks or registered trademarks of AMICAS, Inc. All other company and trademark names are the property of their respective owners.

About AMICAS, Inc.

AMICAS, Inc. (http://www.amicas.com/) is a leader in radiology and medical image and information management solutions. The AMICAS(R) Vision Series(TM) products provide a complete, end-to-end solution for imaging centers, ambulatory care facilities, and radiology practices. Acute care and hospital clients are provided a fully-integrated, HIS/RIS-independent PACS, featuring advanced enterprise workflow support and scalable design. Complementing the Vision Series product family is AMICAS Insight(TM) Solutions, a set of client- centered professional and consulting services that assist our customers with a well-planned transition to a digital enterprise.

CONTACT: Aine Cryts Marketing Communications Manager 617.779.7878acryts@amicas.com

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk, photodesk@prnewswire.com
© 2008 PR Newswire
Vorsicht, geheim!
2026 startet mit einem Paukenschlag: Der DAX outperformt den US-Markt, Nachzügler holen auf. Ein erstes Signal, dass der Bullenmarkt an Breite gewinnt. Während viele Anleger weiter auf die großen Tech-Namen setzen, hat sich im Hintergrund längst ein Umschwung vollzogen. Der Fokus verschiebt sich weg von überteuerten KI-Highflyern hin zu soliden Qualitätswerten aus der zweiten Reihe.

Anleger, die jetzt clever agieren, setzen nicht auf das, was war, sondern auf das, was kommt. Unternehmen mit gesunder Bilanz, unterschätztem Potenzial und begrenztem Abwärtsrisiko könnten 2026 zu den großen Gewinnern zählen. Die Gefahr einer schärferen Korrektur bleibt real, gerade für passiv aufgestellte Investoren.

In unserem neuen Spezialreport stellen wir fünf Aktien vor, die genau jetzt das Potenzial für überdurchschnittliche Renditen bieten. Stark, günstig und bislang kaum im Fokus.

Jetzt kostenlosen Report herunterladen – bevor es andere tun!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.